Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medical Research of Arizona
Scottsdale, Arizona, United States
- Ownership
- Private
- Employees
- ~5
- Development stage
- Other
01
Overview
The site has contributed to clinical trials leading to FDA approvals for drugs such as dupilumab, omalizumab, mepolizumab, reslizumab, C1INH (cinryze), ecallantide (kalbitor), lanadelumab (takhzyro), palforzia, advair, symbicort, and auto-injector/inhaler devices. Outcomes are advances in approved therapies for asthma, allergy, and immunology indications.
- Therapeutic areas
- PulmonologyDermatologyImmunologyRare Diseases
- Modalities
- Small moleculeBiologicMonoclonal antibodyDevice
- Industry
- Contract Research Organization
02
Partnerships
Beyond the preview
Go deeper on Medical Research of Arizona.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Medical Research of Arizona.